Quality of life (QOL) impact of adjuvant chemotherapy for early stage non- small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial

被引：0
|
作者：
Bezjak, A.
Lee, C. W.
Ding, K.
Winton, T.
Brundage, M.
Graham, B.
Whitehead, M.
Seymour, L.
Shepherd, F. A.
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] NCIC CTG, Kingston, ON, Canada
[4] Univ Alberta Hosp, Edmonton, ON, Canada
[5] Kingston Reg Canc Ctr, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7585
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients
    Grinnell, Madison
    Appiah, Adams Kusi
    Baine, Michael
    Ernani, Vinicius
    Marr, Alissa
    Zhang, Chi
    Zhen, Weining
    Buddharaju, Laxmi Narayana R.
    Smith, Lynette M.
    Ganti, Apar Kishor
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (07) : 1145 - 1153
  • [22] Adjuvant chemotherapy for early-stage non-small cell lung cancer
    Visbal, AL
    Leighl, NB
    Feld, R
    Shepherd, FA
    CHEST, 2005, 128 (04) : 2933 - 2943
  • [23] Adjuvant chemotherapy in early-stage non-small cell lung cancer
    Dômont, J
    Soria, JC
    Le Chevalier, T
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 279 - 283
  • [24] Economic analysis of NCIC CTG JBR.10: A randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer - A report of the working group on economic analysis, and the lung disease site group, National Cancer Institute of Canada Clinical Trials Group
    Ng, Raymond
    Hasan, Baktiar
    Mittmann, Nicole
    Florescu, Marie
    Shepherd, Frances A.
    Ding, Keyue
    Butts, Charles Andrew
    Cormier, Yvon
    Darling, Gail
    Goss, Glenwood D.
    Inculet, Richard
    Seymour, Lesley
    Winton, Timothy L.
    Evans, William K.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) : 2256 - 2261
  • [25] A simple versus complicated analysis of quality of life (QOL) data for non-small cell lung cancer (NSCLC)
    Zee, Benny C.
    Mo, Frankie
    Mok, Tony
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S968 - S968
  • [26] Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer
    Kreuter, Michael
    Vansteenkiste, Johan
    Herth, Felix J. F.
    Fischer, Juergen R.
    Eberhardt, Wilfried
    Zuna, Ivan
    Reinmuth, Niels
    Griesinger, Frank
    Thomas, Michael
    RESPIRATION, 2014, 87 (03) : 204 - 210
  • [27] Impact of hemoglobin (Hb) on outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non-small cell lung cancer (NSCLC) in JBR.10.
    Gauthier, I
    Ding, K
    Winton, T
    Shepherd, F
    Livingston, R
    Johnson, DH
    Rigas, JR
    Whitehead, M
    Graham, B
    Seymour, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 670S - 670S
  • [28] Adjuvant chemotherapy in Non Small Cell Lung Cancer (NSCLC) - a feasibility study in the non-trial population
    Treece, S. J.
    Magee, L.
    Gilligan, D.
    Harden, S. V.
    LUNG CANCER, 2007, 57 : S6 - S6
  • [29] Adjuvant chemotherapy inelderly patients with non small cell lung cancer (NSCLC)
    Kritikos, K.
    Heras, P.
    Hatzopoulos, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 387 - 387
  • [30] Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA
    Graziano, Stephen L.
    Lacas, Benjamin
    Vollmer, Robin
    Kratzke, Robert
    Popper, Helmut
    Filipits, Martin
    Seymour, Lesley
    Shepherd, Frances A.
    Rosell, Rafael
    Veillard, Anne Sophie
    Taron, Miquel
    Pignon, Jean-Pierre
    LUNG CANCER, 2013, 82 (01) : 149 - 155
12345